Roche Group member Genentech and Astellas Pharma US announced that the US Food and Drug Administration (FDA) has cleared Tarceva (erlotinib). The tablets are used for the initial treatment of people with metastatic non-small cell lung ...
Tags: FDA, Tarceva Tablets, Astellas Pharma
The bicycle industry may not be as sexy as social media or biotechnology, but Patrick Keating believes it offers plenty of opportunity for investors. Keating, an American financier who lives in France, founded what he hopes will be the ...
Tags: bicycle industry, bicycle, cycling industry
Sue Desmond-Hellmann follows in Sheryl Sandberg’s footsteps and joins the board of Facebook. Sue Desmond-Hellman is currently the Chancellor of the University of California, San Francisco and also services on the board of directors ...
Vernalis has obtained a final payment of $2.5m from its drug discovery collaboration with Genentech, a member of the Roche Group. The collaboration was formed to discover novel small molecules for an undisclosed target using Vernalis' ...
Tags: Vernalis, drug discovery, drug
Modern science is an intensely social activity. The response at colleges and universities is to renovate or build new science labs and medical facilities with open floor plans, shared space and shared equipment. Even with all this openness, ...
Tags: Glass Lab Walls, Collaboration, Sustainability, Safety
The US FDA has approved the use of Genentech's Tamiflu (oseltamivir phosphate) for the treatment of Influenza in infants aged two weeks and more. Tamiflu works by blocking the ability of the virus to replicate in the body thereby ...
Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...
Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...
Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
Genentech, a member of Roche Group, has obtained clearance for its Lucentis 0.3 mg (ranibizumab injection) from the US Food and Drug Administration (FDA). Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an ...
Tags: Genentech, Lucentis 0.3 mg, Medicine, Injection
Mytrus, a provider of clinical technology and services, has appointed Anthony Costello as the company's new chief executive officer (CEO). Costello replaces Steve Cummings, who is now the company's new chief scientific officer and will ...
Tags: clinical technology and services, oncology clinical data management
Dako, a Danish provider of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and HER2 FISH pharmDx Kit as companion diagnostics for pertuzumab (Perjeta) - a new Genentech ...
Tags: Dako, cancer diagnostics solutions, HercepTest, HER2 FISH
The US Food and Drug Administration (FDA) has approved Genentech's Perjeta (pertuzumab) for the treatment of HER2-positive metastatic breast cancer (mBC), in combination with Herceptin (trastuzumab) and docetaxel chemotherapy. The ...
Tags: FDA approval, breast cancer, clinical study, pharmaceutical product
HemCon Medical Technologies, a developer of lyophilized human plasma, has named Barry Starkman as the new chief executive officer (CEO). Previously, Starkman served at Promega as operational vice president, where he was responsible for ...
Tags: lyophilized human plasma, lyophilized plasma, LyP program
Astellas Pharma has announced favorable US court ruling in patent infringement case for OSI Pharmaceuticals, Genentech, a member of the Roche Group, and Pfizer. The US District Court for the District of Delaware has found both the patents ...
Tags: Astellas Pharma, Mylan, lawsuit